With regard to insurance, the basic limitation is that Intravenous Ketamine Therapy has not been approved by the FDA for the treatment of mood disorders. While ketamine is an FDA approved anesthetic, this use is considered off-label. One in three psychiatric medications are prescribed off label in the United States, so this is a common practice and not indicative of a treatment’s effectiveness. It simply means that the medicine has been found to be effective for indications other than what it was originally approved for. As a result, health insurance companies traditionally deny coverage for ketamine treatment for the symptoms of depression and other mood disorders. Therefore, patients should be aware that insurance reimbursement has been inconsistent and partial, if at all. However, more and more insurers are partially reimbursing patients who submit the correct superbills or statements after treatment.
Dr. Steven Mandel and his team will clearly advise patients on issues related to payment, financing, and the possibility of securing ketamine insurance coverage. Ketamine Clinics Los Angeles has put together very effective statements to give you the best chance of reimbursement. Patients should note that individual insurance plans vary significantly and no one company has a policy that applies to all plans. Therefore, it is a good idea to contact the insurance company and discuss the possibility of Ketamine Infusion insurance coverage to help cover the cost of treatment.
Dr. Mandel and his team will clearly advise patients on issues related to payment, financing and insurance possibility for Ketamine Infusion Therapy. With regard to insurance, the basic limitation until now is that Ketamine Therapy has not been approved by the FDA. The use of ketamine for treating major depressive disorders is currently off-label and off-patent.
As a result, the opportunity for extensive clinical trials to demonstrate the safety and efficacy of Ketamine Infusion Therapy is very limited at present. Health insurance companies traditionally want to deny coverage for ketamine treatments for the symptoms of depression. Therefore, patients should be made aware that insurance reimbursement is unlikely for treatment.
However, patients should also note that individual insurance plans can significantly vary. Therefore, it is a good idea to contact the insurance company and discuss with them about the possibility of coverage for Ketamine Therapy to treat the symptoms of depression.
Safe and Proven Procedure
Ketamine was synthesized more than half a century ago, and has been in medical use since 1970. In fact, it is the most widely used anesthetic in the world and has been administered hundreds of millions of times safely. There is decades of information, data, patient response, and results of clinical ketamine use, which is more than most other medications available for mood today. Even though the application is different, we know ketamine to be a very safe medicine. Ketamine has been researched for the treatment of mood disorders and chronic pain conditions for approximately 20 years, so there is a substantial amount of data supporting its efficacy and safety.
Compared to traditional antidepressants, ketamine has been used on a much larger population for a much longer period of time – with successful outcomes and without any apparent long term side effects. Therefore, logically, insurance companies have little or no justification not to pay for Ketamine Infusion Therapy. With the recent FDA approval of Spravato or Esketamine for depression,which is essentially ketamine, it is increasingly difficult for insurers to justify not paying for IV ketamine treatments.
Credibility of Ketamine Treatment
Patients should make an objective assessment, and not be influenced by the fact that Ketamine covered by insurance is uncertain. Underlying reasons for this could be that many pharmaceutical companies do not want to see ketamine used therapeutically because it threatens their less effective drugs which can be sold for more money. Insurance companies do not want to accept ketamine as a credible treatment for depression and other mood disorders because they dont pay unless they have to. If they ran the numbers though, they would probably find paying for ketamine for depression to save them money, not cost more.
Researchers have proven Ketamine Infusion Therapy’s efficacy to exceed that of conventional antidepressants in many cases, and there is a broader view developing in the medical community that ketamine deserves to be considered a mainstream procedure to address symptoms of depression now.
The vested interests of big pharma and insurance companies, if any, should not be a hurdle for patients to enjoy the benefits of Ketamine Infusion Therapy and get relief from their symptoms of depression. International ketamine treatment expert Dr. Mandel has pioneered ketamine for depression since early 2014 and welcomes patients from Los Angeles, Westchester, Beverly Hills, Venice, Marina del Rey, Culver City, California, other areas in the US and abroad for ketamine infusion treatments.
Credibility of Ketamine Treatment
Ketamine Therapy is a viable treatment for patients with major depressive disorders and other mental health and pain related conditions.
Ketamine Clinics of Los Angeles, led by compassionate and experienced Dr. Steven L Mandel, is a state of the art practice providing Ketamine Therapy in a safe, relaxing, and professional environment. During the initial consultation, Dr. Mandel will educate the patient about various aspects of ketamine and address their questions. He provides ketamine infusion treatments to patients in Los Angeles, Westchester, Beverly Hills, Venice, Marina del Rey, Culver City, California, other areas in the US and abroad.
For more information about treatments for depression, bipolar, anxiety, post-traumatic stress disorder (PTSD), obsessive compulsive disorder (OCD), fibromyalgia, pain syndromes and other conditions contact us at the Ketamine Clinics of Los Angeles in Southern California (Orange County) by clicking here or calling 310-270-0625
Treating patients from LA, Beverly Hills, Orange County, San Diego, Palm Springs, San Francisco, Sacramento,CA, Las Vegas, NV and many other cities from west to east coast.